Skip to main content
BMJ Case Reports logoLink to BMJ Case Reports
. 2013 Aug 23;2013:bcr2013009087. doi: 10.1136/bcr-2013-009087

Candida dubliniensis encrustation of an obstructing upper renal tract calculus

Dermot O'Kane 1, Anthony Kiosoglous 1, Kay Jones 2
PMCID: PMC3762057  PMID: 23975908

Abstract

We present the case of a 53-year-old man, with a history of alcohol abuse, requiring intensive care unit admission, with an obstructing right upper renal calculus and Klebsiella pneumoniae urosepsis. Ureteroscopic treatment of this obstruction displayed a small calculus within the renal pelvis completely encapsulated within a fungal bezoar. Laboratory analysis of the fungal mass found it to be Candida dubliniensis.

Background

This case demonstrates a very unusual endoscopic finding, and a very uncommon cause of renal tract obstruction.

Case presentation

This man presented to the emergency department at a tertiary referral hospital in Queensland, Australia, with a short history of right flank pain, diarrhoea, vomiting, fever and malaise. He had a history of known hypoplastic left kidney, previous alcohol abuse, with alcoholic liver disease and gout.

This patient required intensive care unit admission with urosepsis. He was found to be in acute renal failure with hyperkalaemia and metabolic acidosis.

Investigations

Non-contrast CT abdomen showed an enlarged right kidney with moderate dilation of the pelvicalyceal system. There was a 1.6 cm calculus in the right renal pelvis with moderate dilation of the proximal third of right ureter.

Differential diagnosis

Upper renal tract calculus.

Treatment

The patient was taken to the operating theatre for emergency insertion of a right ureteric stent. The patient required prolonged invasive ventilation and tracheostomy postoperatively. The blood and urine cultures confirmed Klebsiella pneumoniae infection. He was treated with intravenous ceftriaxone and gentamicin in the intensive care unit. Gentamicin was ceased after 4 days. Ceftriaxone was continued for a total of 14 days. On day 11 the patient had positive Candida albicans growth from a catheter urine sample. Fluconazole treatment was started, and discontinued after 3 days. An indwelling urethral catheter was removed on day 12 when the patient developed a malodorous urethral discharge. Urethral swabs grew C albicans and mixed skin flora. C albicans was identified on both occasions with a positive germ tube. The patient's clinical status improved and he returned to the renal ward. The patient required regular haemodialysis for 3 weeks. His renal function improved and he was discharged on day 34. The offending renal calculus was radiolucent on X-ray KUB (kidneys, ureters and bladder) and therefore theoretically amenable to dissolution therapy with sodium bicarbonate, which was initiated on discharge.

The patient was followed up at the urology outpatient clinic. Progress imaging (CT KUB) showed failure of dissolution therapy. Definitive surgical treatment was delayed due to patient comorbidities, namely; alcoholic liver disease, failure to abstain from alcohol and laryngeal stenosis following tracheostomy, perturbing general anaesthesia with endotracheal intubation. Following a review by the Ear Nose and Throat specialists, rigid cystoscopy, ureteroscopy and laser lithotripsy of the renal stone were performed under general anaesthetic 12 months following the patient's discharge. A retrograde pyelogram showed a filling defect in the renal pelvis measuring approximately 3 cm in diameter (figure 1). This was unexpected based on CT KUB measurements of the calculus 2 weeks prior as 12×8×16 mm (figure 2). Rigid ureteroscopy demonstrated a brown/green amorphous mass within the renal pelvis, which was clot-like in texture. Ureteroscopic debridement of this material displayed the underlying renal calculus. This calculus was fragmented using laser lithotripsy and retrieved. Samples of the amorphous debris surrounding the calculus were sent for microbiology (figure 3). Fungal growth with Candida dubliniensis was confirmed.

Figure 1.

Figure 1

Retrograde pyelogram displaying a large (30 mm) filling defect within the right renal pelvis.

Figure 2.

Figure 2

Non-contrast CT abdomen displaying the offending right renal calculus (12×8×16 mm).

Figure 3.

Figure 3

Wet preparation of hyphal mass (magnification ×400).

Outcome and follow-up

This patient had a good recovery following his endoscopic procedure. Repeat urine microscopy did not show any bacteriuria or funguria.

Discussion

Fungal bezoars are concretions of fungal material within the renal tract, and have been reported in patients with florid fungal pyelonephritis as well as asymptomatic funguria. Fungal bezoars are usually seen in the immunocompromised patient or in the patient with diabetes or a chronic alcoholic, particularly with prolonged urethral catheterisation and prolonged courses of antibiotics.1 There are some reports of Candida bezoars in patients without immunocompromising conditions.2 Fungal bezoars are rarely encountered in clinical practice. Schonebeck and Ansehn (1972) noted only 29 cases in the literature of upper renal tract fungal bezoars, and approximately 50 cases have been reported since then.3 Candida species are the most common offending fungi involved, but there have been reports of Aspergillus species in the literature.4

C dubliniensis is a relatively recently discovered Candida species, first described by Sullivan et al in 1995. It was first isolated from the oral cavities of HIV-infected patients. It has since also been isolated from sputum samples, faeces samples, vaginal and penile swabs, as well as from urine samples, from HIV-infected and non-HIV-infected patients.5 C dubliniensis isolation from urine is relatively uncommon; indeed, only a small number of cases have been reported in the literature.6 Between the multiple centres that comprise Queensland Health, Australia, with a patient population of about 4.5 million people, there have only been 98 isolates of C dubliniensis from 63 different patients, since 2000. There have only been three isolates from urine samples, all of which have been from non-HIV infected individuals. This number is likely an underestimation of the prevalence of C dubliniensis isolates from urine as Candida species are rarely fully speciated when isolated from urine, and identification as C albicans or non-albicans is decided by germ tube alone. Full identification and susceptibility testing, as in this case, is only carried out for invasive or serious infection or isolation from sterile sites to ensure susceptibility to the chosen antifungal.

C dubliniensis can easily be confused with C albicans as both can produce hyphae and are therefore germ tube positive; however, most isolates of C dubliniensis do not form germ tubes in a commercial synthetic germination medium and remain mostly germ tube negative in the laboratory.7 Differentiation between C albicans and C dubliniensis may require testing for growth at 45°C; however, results are not definitive. Chromogenic Candida agar is not routinely used in all centres due to high cost. Differentiation between the two yeasts should only be carried out for invasive or serious infections or in case of concern about resistance.

Initial reports at the time of the discovery of C dubliniensis during the HIV and fluconazole prophylaxis era revealed many isolates with elevated minimum inhibitory concentrations to fluconazole under antifungal selection pressure.8 Subsequent reports by the same authors showed that C dubliniensis has remained fairly susceptible to fluconazole.9 Further work by Lockhart10 has revealed resistance of C dubliniensis to fluconazole in only 2/42 isolates. Other recent studies show rates of resistance ranging from 3.1% to 3.9% in 65 and 310 isolates, respectively.11 12 It was important to identify the susceptibility of this isolate in this case to ensure susceptibility to therapy.

We have failed to find any cases in the literature to date of C dubliniensis fungal bezoars of the renal tract.

Learning points.

  • Fungal bezoars of the renal tract are uncommon, but can occur in certain patients under certain conditions—immunocompromised, intensive care unit, prolonged renal tract foreign body (stent, etc).

  • Fungal bezoar of the renal tract is an uncommon cause for failure of dissolution therapy of what might be assumed to be a uric-acid calculus based on imaging (radiolucent on plain X-ray).

  • In the advent of increasing numbers of drug-resistant bacterial and fungal pathogens, uncommon presentations of fungal pathogens within the renal tract may become more common.

Footnotes

Contributors: DOK is the main author, responsible for data collection and literature review, design and prepartation of the final draft. AK is the supervisor and was involved in revision of final draft, data collection. KJ is responsible for data collection, drafting portions of the case, microbiology advise and revision of final draft.

Competing interests: None.

Patient consent: Obtained.

Provenance and peer review: Not commissioned; externally peer reviewed.

References

  • 1.Schönebeck JS, Ånséhn S. The occurrence of yeast-like fungi in the urine under normal conditions and in various types of urinary tract pathology. Scand J Urol Nephrol 1972;2013:123–8 [DOI] [PubMed] [Google Scholar]
  • 2.Di Paola G, Mogorovich A, Girolamo G, et al. Candida bezoars with urinary tract obstruction in two women without immunocompromising conditions. Sci World J 2011;2013:1168–72 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Scerpella EG, Alhalel R. An unusual cause of acute renal failure; bilateral ureteric obstruction due to Candida tropicalis fungus balls. Clin Infect Dis 1994;2013:440–2 [DOI] [PubMed] [Google Scholar]
  • 4.Ahuja A, Aulakh BS, Cheena DK, et al. Aspergillus fungal balls causing ureteral obstruction. Urol J 2009;2013:127–9 [PubMed] [Google Scholar]
  • 5.Pinjon E, Sullivan D, Salkin I, et al. Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans. J Clin Microbiol 1998;2013:2093–5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Polacheck I, Strahilevitz J, Sullivan D, et al. Recovery of Candida dubliniensis from non-human immunodefieciency virus-infected patients in Israel. J Clin Microbiol 2000;2013:170–4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Odds FC, Van Nuffell L, Dams G. Prevalence of Candida dubliniensis isolates in a yeast stock collection. J Clin Microbiol 1998;2013:2869–73 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Moran GP, Sullivan DJ, Henman MC, et al. Antifungal drug susceptibilities of oral Candida dubliniensis isolates from the human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro. Antimicrob Agents Chemother 1997;2013:617–23 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Pinjon E, Moran GP, Coleman DC, et al. Azole susceptibility and resistance in Candida dubliensis. Biochem Soc Trans 2005;2013:1210–14 [DOI] [PubMed] [Google Scholar]
  • 10.Lockhart SR. Do hospital microbiology laboratories still need to distinguish Candida albicans from Candida dubliniensis? J Clin Microbiol 2011;2013:4415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Arendrup MC, Bruun B, Christensen JJ, et al. National surveillance of fungaemia in Denmark (2004 to 2009). J Clin Microbiol 2011;2013:325–34 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Pfaller MA, Diekema DJ, Gibbs DL, et al. Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5 year analysis of susceptibilities of Candida species to fluconazole and voriconazole as determined by CLSI standardized disc diffusion. J Clin Microbiol 2010;2013:1366–77 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ Case Reports are provided here courtesy of BMJ Publishing Group

RESOURCES